Veracyte (VCYT)
(Delayed Data from NSDQ)
$20.12 USD
-0.91 (-4.33%)
Updated May 8, 2024 04:00 PM ET
After-Market: $16.89 -3.23 (-16.05%) 5:52 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Price, Consensus and EPS Surprise
VCYT 20.12 -0.91(-4.33%)
Will VCYT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for VCYT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VCYT
Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
VCYT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Veracyte's (VCYT) Q4 Loss Widens, Gross Margin Expands
Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates
3 Medical Instruments Stocks to Buy as Industry Trends Improve
Other News for VCYT
Veracyte price target lowered by $6 at Needham, here's why
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), Veracyte (VCYT) and Nevro Corp (NVRO)
Maintaining Buy on Veracyte: Strong Q1 Performance and Progress Toward Profitability
Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue ...
Veracyte: Q1 Earnings Snapshot